CELLECTAR BIOSCIENCES INC (CLRB) Stock Income Statement
NASDAQ:CLRB - Nasdaq - US15117F8077 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 46.18M | 51.78M | 38.96M | 28.81M | 24.13M | |||
| Research and Development | 22.48M | 26.14M | 27.27M | 19.22M | 17.59M | |||
| Selling, General, and Administrative Expenses | 23.70M | 25.64M | 11.69M | 9.59M | 6.54M | |||
| Operating Income | -46.18M | -51.78M | -38.96M | -28.81M | -24.13M | |||
| Interest Income/Expense | 21.70M | 7.26M | -3.87M | 150.00K | 0.00 | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | 10.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -24.48M | -44.52M | -42.83M | -28.66M | -24.12M | |||
| Income Tax | N/A | 66.00K | -60.00K | -60.00K | 0.00 | |||
| Net Income | -24.54M | -44.58M | -42.77M | -28.60M | -24.12M | |||
| EBITDA | -45.92M | -51.49M | -38.77M | -28.66M | -23.98M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.60 | -1.22 | -3.50 | -4.05 | -4.35 | |||
| Non GAAP EPS | -0.63 | -1.23 | -2.93 | -4.05 | -4.30 | |||
| Statistics | ||||||||
All data in USD